https://doi.org/10.1016/s1470-2045(14)70442-5
J
Jo Caers
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
232
Papers
12.0K
Citations
39
h-index
78
i10-index
Jo Caers is an academic researcher from University of Liège. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Protein Degradation and Inhibitors & Cancer Treatment and Pharmacology. The author has an h-index of 39, co-authored 198 publications.
ORCID: 0000-0002-3175-1195Papers by this author
worksInternational Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
2014 · The Lancet Oncology · 4,761 citations
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
2012 · Leukemia · 377 citations
https://doi.org/10.1038/leu.2012.336
Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel
2018 · Journal of Hematology & Oncology · 312 citations
https://doi.org/10.1186/s13045-017-0549-1
Extramedullary disease in multiple myeloma: a systematic literature review
2022 · Blood Cancer Journal · 250 citations
https://doi.org/10.1038/s41408-022-00643-3
Expert review on soft‐tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations
2021 · British Journal of Haematology · 165 citations
https://doi.org/10.1111/bjh.17338
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage
2021 · Blood Cancer Journal · 164 citations
https://doi.org/10.1038/s41408-021-00587-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat